Literature DB >> 8044103

Hormone replacement therapy. Should be used selectively.

J C Stevenson, M Baum.   

Abstract

Mesh：

Year:  1994        PMID： 8044103      PMCID： PMC2540665     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Postmenopausal oestrogen and cardioprotection.

Authors:  J P Vandenbroucke
Journal:  Lancet       Date:  1991-04-06       Impact factor: 79.321

2.  Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?

Authors:  W F Posthuma; R G Westendorp; J P Vandenbroucke
Journal:  BMJ       Date:  1994-05-14

3.  Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis.

Authors:  K Hunt; M Vessey; K McPherson
Journal:  Br J Obstet Gynaecol       Date:  1990-12

4.  Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.

Authors:  M J Stampfer; G A Colditz; W C Willett; J E Manson; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1991-09-12       Impact factor: 91.245

5.  Compliance with hormone therapy.

Authors:  V A Ravnikar
Journal:  Am J Obstet Gynecol       Date:  1987-05       Impact factor: 8.661
  5 in total
  2 in total

1.  Cardioprotective effect of hormone replacement therapy. Is not due to selection bias.

Authors:  M Stampfer; F Grodstein
Journal:  BMJ       Date:  1994-09-24

2.  Raloxifene: mechanism of action, effects on bone tissue, and applicability in clinical traumatology practice.

Authors:  Jose R Caeiro Rey; Eduardo Vaquero Cervino; Maria Luz Rentero; Emilio Calvo Crespo; Angel Oteo Alvaro; Marta Casillas
Journal:  Open Orthop J       Date:  2009-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.